RBI
ALLO icon

Raiffeisen Bank International’s Allogene Therapeutics ALLO Stock Holding History

Raiffeisen Bank International’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.16K Hold
2,000
– – ﹤0.01% 751
2026
Q1 		$4.88K Hold
2,000
– – ﹤0.01% 784
2025
Q4 		$2.2K Hold
2,000
– – ﹤0.01% 775
2025
Q3 		$2.48K Buy
+2,000
New +$2.38K ﹤0.01% 783

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Raiffeisen Bank International's ALLO Position: Q2 2026 in Review

Raiffeisen Bank International increased its Allogene Therapeutics (ALLO) stake by 57% in Q2 2026, buying an estimated $878K and bringing the position to 1,100,000 shares worth $2.44M. The position accounts for 0.03% of the portfolio, ranked #275.

Raiffeisen Bank International first reported a position in ALLO in Q4 2024 and has held it in 7 quarters since. 71 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • Raiffeisen Bank International held 1,100,000 shares of Allogene Therapeutics worth $2.44M as of Q2 2026.
  • Raiffeisen Bank International bought 400,000 Allogene Therapeutics shares in Q2 2026, an estimated $878K.
  • Allogene Therapeutics made up 0.03% of Raiffeisen Bank International's portfolio in Q2 2026, its #275 holding.
  • Raiffeisen Bank International first reported a position in Allogene Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 71 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.